Blood cancers

Use of CD38 antibodies in multiple myeloma and AL amyloidosis: Janssen H3 2021

Sponsored by Janssen-Cilag Pty Ltd

The Janssen H3 medical education meeting on haematological malignancies was held on 8 May 2021, both virtually and live across six locations in Australia and New Zealand. Chaired by Dr Wojt Janowski of the Calvary Mater in Newcastle, NSW, the dinner session featured a presentation from international guest speaker Professor Wee Joo Chng, Director of ...

Already a member?

Login to keep reading.

© 2021 the limbic